MicroPort® EP Receives Approval to be Quoted on NEEQ
Shanghai, China - On July 28, Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort® EP") received approval notification relating to the quotation of the shares of MicroPort® EP on the National Equities Exchange and Quotations ("NEEQ").
MicroPort® EP primarily focuses on developing, manufacturing, and marketing of minimally invasive medical devices for the treatment of electrophysiological diseases, such as 3D cardiac mapping system, ablation catheter, and diagnosis catheter. The approval of quotation of MicroPort® EP on the NEEQ will enhance its corporate profile, enable it to have a better fund-raising platform, and increase its ability to attract strategic investors.
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.